Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials and compliance.
CIN U24231GJ1994PLC022787 Incorporated 17 August 1994 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹120.09 Cr
▼ 4.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.38 Cr
Issued & subscribed
Open charges
₹6.8 Lakh
Satisfied ₹9.3 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
780
Latest available

About Shine Pharmaceuticals Limited

Data last updated: 18 December 2025

Shine Pharmaceuticals Limited is a public limited company based in Vadodara, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 August 1994, the company has been in operation for over 32 years.

Registered with ROC Ahmedabad under CIN U24231GJ1994PLC022787.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.38 Cr. Formerly known as Shine Pharmaceuticals Private Limited. It is led by directors including Tejal Ashish Parikh and Hiranmay Saha.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Vadodara, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹120.09 Cr, a decline of 4% compared to the previous year.

The company has a workforce of approximately 780 employees as per the latest available data.

The company is associated with 1 brand - Shine Pharmaceuticals. As per MCA filings, the company has open charges of ₹6.8 Lakh and satisfied charges of ₹9.3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shinepharma.com.

Company Details of Shine Pharmaceuticals Limited
CIN U24231GJ1994PLC022787
Registration Number 022787
Incorporation Date 17 August 1994
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    309 – 310 Dwarkesh Complex 3Rd Floor Sun Pharma Road Off. Old Padra Road At, Ladara, Vadodara, Gujarat, India – 390012
  • Industry
    Pharma, Drug Formulation & Development
Company report
Shine Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Shine Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Shine Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U24231GJ1994PTC022787. The current CIN is U24231GJ1994PLC022787, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24231GJ1994PLC022787 Current
U24231GJ1994PTC022787 Previous

Associated Brands with Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited operates one associated brand: Shine Pharmaceuticals. These brands represent Shine Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
Specialty pharmaceutical company producing formulations for psychiatry, cardiology, and gastroenterology. shinepharma.com

Competitors & Alternatives of Shine Pharmaceuticals Limited

Brands and companies operating in the same space as Shine Pharmaceuticals Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Shine Pharmaceuticals Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited is audited by Shah Sanghvi & Co for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Shah Sanghvi & Co Locked Locked Locked
Premium access

Complete auditor history for Shine Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited is currently managed by 6 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Tejal Ashish Parikh Director 30 Mar 2024 2 Years 3 Months Current
Hiranmay Saha Director 30 May 1996 30 Years 1 Months Current
Samir Chakraborty Managing Director 01 Apr 2005 21 Years 3 Months Current
Rangoli Saurav Gada Director 25 Mar 2023 3 Years 3 Months Current
Aloka Saha Whole-Time Director 30 May 1996 30 Years 1 Months Current
Pradeep Vishambhar Agrawal Whole-Time Director 01 Jul 2003 23 Years 0 Months Current

Financials of Shine Pharmaceuticals Limited FY 2025 filings available

Shine Pharmaceuticals Limited reported revenue of ₹120.09 Cr (down 4.00% YoY) for FY 2025.

Revenue · FY 2025
₹120.09 Cr ▼ 4.00%
Premium access

Ten-year financial statements for Shine Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Shine Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Shine Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Shine Pharmaceuticals Limited

Open charges
₹6.8 Lakh
Satisfied charges
₹9.3 Cr
Breakdown by lending institutions
Axis Bank Limited₹0.07 Cr
Latest charge details
DateLenderAmountStatus
29 Jun 2019 Axis Bank Limited ₹6.8 Lakh Open
24 Dec 2020 Others ₹2 Cr Satisfied
26 Sep 2019 Others ₹75 Lakh Satisfied
03 Jan 2004 Bank of Baroda ₹3.55 Cr Satisfied
05 Jul 2003 Bank of Baroda ₹3 Cr Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited has a workforce of 780 employees as of Mar 26, 2025.

Employee count
780
Active EPFO establishments
7
Employee growth
4.84%
Premium access

Employee and EPFO history for Shine Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Shine Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Shine Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Shine Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Shine Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Shine Pharmaceuticals Limited

Premium access

MSME payment history for Shine Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Shine Pharmaceuticals Limited

Premium access

Corporate group structure for Shine Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Shine Pharmaceuticals Limited

Premium access

MCA filings and documents for Shine Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Shine Pharmaceuticals Limited

Activity
30 Sep 2025
Shine Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Shine Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
30 Mar 2024
Tejal Ashish Parikh was appointed as a Director on 30 Mar 2024 & has been associated with this company since 2 years 3 months.
Charges
21 Mar 2024
A charge registered on 24 Dec 2020 via Charge ID 100397788 with Others was fully satisfied on 21 Mar 2024.
Directors
25 Mar 2023
Rangoli Saurav Gada was appointed as a Director on 25 Mar 2023 & has been associated with this company since 3 years 3 months.
Charges
30 Mar 2022
A charge registered on 26 Sep 2019 via Charge ID 100294266 with Others was fully satisfied on 30 Mar 2022.

Frequently Asked Questions about Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited is an active public limited company in the pharma sector based in Vadodara, Gujarat, India. It was incorporated on 17 August 1994 (32+ years old) and is registered under CIN U24231GJ1994PLC022787. The company has 780 employees.

Shine Pharmaceuticals Limited reported revenue of ₹120.09 Cr for FY 2025 (down 4.00% YoY).

The current directors of Shine Pharmaceuticals Limited are:

The primary industry of Shine Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Shine Pharmaceuticals Limited can be reached at the registered office: 309 – 310 Dwarkesh Complex 3Rd Floor Sun Pharma Road Off. Old Padra Road At, Ladara, Vadodara, Gujarat, India – 390012, or through the website shinepharma.com.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹3.38 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available